High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3581-3588

  Peters, Hilde P E ^a   Waanders, Femke ^b   Meijer, Esther ^b   Van Den Brand, Jan ^a   Steenbergen, Eric J ^a   Van Goor, Harry ^b   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

biomarker; end stage renal disease; IgA nephropathy; KIM 1; NGAL

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN G; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; URINARY EXCRETION;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; PROGNOSIS; PROTEINURIA; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RENAL DIALYSIS;

EID: 80155210291     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr135     Document Type: Article

References (38)

1. D'Amico G. Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 1988; 12: 353-357
2. Radford MG Jr, Donadio JV Jr, Bergstralh EJ et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207
3. Frimat L, Briancon S, Hestin D et al. IgA nephropathy: Prognostic classification of end-stage renal failure. L'Association des Nephrologues de l'Est. Nephrol Dial Transplant 1997; 12: 2569-2575
4. Pozzi C, Andrulli S, Del VL et al. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157-163
5. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13: 142-148
6. Yoshikawa N, Honda M, Iijima K et al. Steroid treatment for severe childhood IgA nephropathy: A randomized, controlled trial. Clin J Am Soc Nephrol 2006; 1: 511-517
7. Beukhof JR, Kardaun O, SchaafsmaWet al. Toward individual prognosis of IgA nephropathy. Kidney Int 1986; 29: 549-556
8. Bogenschutz O, Bohle A, Batz C et al. IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 1990; 10: 137-147
9. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 1997; 29: 526-532
10. Li PK, Ho KK, Szeto CC et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant 2002; 17: 64-69
11. D'Amico G, Minetti L, Ponticelli C et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986; 59: 363-378
12. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842
13. Donadio JV, Bergstralh EJ, Grande JP et al. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002; 17: 1197-1203
14. Alamartine E, Sabatier JC, Guerin C et al. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18: 12-19
15. Cattran DC, Coppo R, Cook HT et al. The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545
16. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
17. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183
18. Bohle A, Kensen-Haen S, von Gise H et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990; 186: 135-144
19. Reichert LJ, Koene RA, Wetzels JF. Urinary excretion of beta 2- microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 1995; 6: 1666-1669
20. Branten AJ, du Buf-Vereijken PW, Klasen IS et al. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: A validation study. J Am Soc Nephrol 2005; 16: 169-174
21. Bazzi C, Petrini C, Rizza V et al. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 2001; 38: 240-248
22. Peters HP, van den Brand JA, Wetzels JF. Urinary excretion of lowmolecular- weight proteins as prognostic markers in IgA nephropathy. Neth J Med 2009; 67: 54-61
23. Han WK, Bailly V, Abichandani R et al. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-244
24. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalinsiderophore- iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621
25. van Timmeren MM, van den Heuvel MC, Bailly V et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212: 209-217
26. Kramer AB, van Timmeren MM, Schuurs TA et al. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am J Physiol Renal Physiol 2009; 296: F1136-F1145
27. van Timmeren MM, Bakker SJ, Vaidya VS et al. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 2006; 291: F456-F464
28. Vaidya VS, Ramirez V, Ichimura T et al. Urinary kidney injury molecule- 1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290: F517-F529
29. van Timmeren MM, Vaidya VS, van Ree RM et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007; 84: 1625-1630
30. Vaidya VS, Waikar SS, Ferguson MA et al. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans. Clin Transl Sci 2008; 1: 200-208
31. Ding H, He Y, Li K et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007; 123: 227-234
32. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543
33. Jacobs EM, Vervoort G, Branten AJ et al. Atrial natriuretic peptide increases albuminuria in type I diabetic patients: Evidence for blockade of tubular protein reabsorption. Eur J Clin Invest 1999; 29: 109-115
34. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
35. Ichimura T, Asseldonk EJ, Humphreys BD et al. Kidney injury molecule- 1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008; 118: 1657-1668
36. de Borst MH, van Timmeren MM, Vaidya VS et al. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol 2007; 292: F313-F320
37. Waanders F, Vaidya VS, van GH et al. Effect of renin- angiotensinaldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: A post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2009; 53: 16-25
38. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238